Hanzlikova, H., Gittens, W., Krejcikova, K., Zeng, Z
For disc herniations where inflammation drives both pain and degeneration, omega-3s provide baseline anti-inflammatory support that complements the anti-inflammatory effects of peptides
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
Most people looking to enhance their wellness are good candidates for IM injections
Interactions of pathogenic neisseriae with epithelial cell membranes
That said, several important safety considerations remain: No FDA approval : BPC-157 is not approved by the U.S